The Framingham Heart Study--67 years of discovery in metabolic disease

Nature Reviews. Endocrinology
Michelle T Long, Caroline S Fox

Abstract

The Framingham Heart Study (FHS), initiated in 1948, is the longest running prospective cohort study in the USA. Through >65 years of discovery, the FHS has contributed to our understanding of obesity, type 2 diabetes mellitus and prediabetes mellitus, the metabolic syndrome and nonalcoholic fatty liver disease (NAFLD), and to how these conditions relate to our overall and cardiovascular-related mortality. This Timeline gives an overview of the substantial role the FHS has played in advancing the understanding of obesity, diabetes mellitus and NAFLD, and considers the direction the FHS will take in the years to come.

References

May 11, 1979·JAMA : the Journal of the American Medical Association·W B Kannel, D L McGee
Jan 1, 1991·Journal of Clinical Epidemiology·W B KannelM Higgins
Jul 1, 1974·The American Journal of Cardiology·W B KannelW P Castelli
Feb 1, 1982·The Journal of Clinical Endocrinology and Metabolism·A H KissebahP W Adams
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Aug 2, 2002·The New England Journal of Medicine·Satish KenchaiahRamachandran S Vasan
Aug 28, 2002·Archives of Internal Medicine·Peter W F WilsonWilliam B Kannel
Oct 9, 2002·JAMA : the Journal of the American Medical Association·Katherine M FlegalClifford L Johnson
Apr 1, 1957·American Journal of Public Health and the Nation's Health·T R DAWBERG V MANN
Nov 25, 2004·JAMA : the Journal of the American Medical Association·Thomas J WangEmelia J Benjamin
Nov 25, 2004·JAMA : the Journal of the American Medical Association·Caroline S FoxPeter J Savage
Mar 14, 2007·The American Journal of Medicine·Nisha I ParikhRamachandran S Vasan
May 30, 2007·Archives of Internal Medicine·Peter W F WilsonRalph B D'Agostino
Jul 27, 2007·The New England Journal of Medicine·Nicholas A Christakis, James H Fowler
Oct 16, 2007·BMC Medical Genetics·James B MeigsJosée Dupuis
Jan 22, 2008·Journal of the American College of Cardiology·Yamini S LevitzkyCaroline S Fox
Nov 21, 2008·The New England Journal of Medicine·James B MeigsL Adrienne Cupples
Dec 9, 2008·Nature Genetics·Inga ProkopenkoGonçalo R Abecasis
Mar 26, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Elizabeth K SpeliotesCaroline S Fox
Jan 20, 2011·Journal of Computer Assisted Tomography·Houchun Harry HuVicente Gilsanz
Mar 23, 2011·Nature Medicine·Thomas J WangRobert E Gerszten
Oct 14, 2011·The Journal of Clinical Endocrinology and Metabolism·Michael SpencerPhilip A Kern
Dec 14, 2011·Circulation·Kathryn A Britton, Caroline S Fox

❮ Previous
Next ❯

Citations

Oct 27, 2016·Circulation. Cardiovascular Genetics·Jonathan D MosleyDan M Roden
Feb 23, 2019·Journal of Endocrinological Investigation·M Federici
Nov 29, 2017·Expert Review of Vaccines·Richard Aspinall, Pierre Olivier Lang
Aug 30, 2017·Multiple Sclerosis : Clinical and Laboratory Research·Riley BoveUNKNOWN SUMMIT Consortium
May 16, 2019·Oxidative Medicine and Cellular Longevity·Chi XiaoLing-Bo Qian
Nov 20, 2016·Epigenomics·Karen A MatherJohn Bj Kwok
Oct 6, 2017·JCI Insight·Kristina WalleniusNicholas D Oakes
Jun 22, 2019·The Journal of Clinical Endocrinology and Metabolism·Mariam HaffaDominique Scherer
Apr 28, 2018·BMC Systems Biology·Frank KramerTanja Zeller
Aug 28, 2019·The Lancet Global Health·Ambroise Wonkam, Julie Makani
Mar 6, 2021·Molecular and Cellular Endocrinology·Hailuan ZengJingyan Tian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.